|
NanoMatrix Inc
magnetic-activated cell sorting (macs) gmpt cell transact reagent Magnetic Activated Cell Sorting (Macs) Gmpt Cell Transact Reagent, supplied by NanoMatrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/magnetic+activated+cell+sorting++macs++gmpt+cell+transact+reagent/10__1200_slash_go___24___00581-46-5-17 Average 90 stars, based on 1 article reviews
magnetic-activated cell sorting (macs) gmpt cell transact reagent - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
NanoTag Biotechnologies GmbH
alfa–biotin antibody nanotag Alfa–Biotin Antibody Nanotag, supplied by NanoTag Biotechnologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/alfa+biotin+antibody+nanotag/pmc11666456-458-10-17 Average 90 stars, based on 1 article reviews
alfa–biotin antibody nanotag - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Corning Life Sciences
magnetic-activated cell sorting buffer (mb) Magnetic Activated Cell Sorting Buffer (Mb), supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/magnetic+activated+cell+sorting+buffer++mb+/bio_rxiv__2024__06__03__597215-237-9-19 Average 90 stars, based on 1 article reviews
magnetic-activated cell sorting buffer (mb) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Zymo Research
concentrator 5 kit zymo research Concentrator 5 Kit Zymo Research, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/DNA+Clean+%26+Concentrator-5+Kit/pm32783886-552-256-258 Average 99 stars, based on 1 article reviews
concentrator 5 kit zymo research - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
pre cooled facs buffer Pre Cooled Facs Buffer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/MACS+BSA+Stock+Solution/pmc10540680-126-8-14 Average 97 stars, based on 1 article reviews
pre cooled facs buffer - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Zymo Research
recombinant proteins dna rna shield zymo research cat Recombinant Proteins Dna Rna Shield Zymo Research Cat, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/DNA%2FRNA+Shield/pm36543165-216-16-20 Average 95 stars, based on 1 article reviews
recombinant proteins dna rna shield zymo research cat - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cell sorting murine lineage cell depletion kit Cell Sorting Murine Lineage Cell Depletion Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/Lineage+Cell+Depletion+Kit%2C+human/pmc03272979-65-10-17 Average 96 stars, based on 1 article reviews
cell sorting murine lineage cell depletion kit - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
magnetic activated cell sorted lineage cell depletion kit Magnetic Activated Cell Sorted Lineage Cell Depletion Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/Lineage+Cell+Depletion+Kit%2C+mouse/10__1161_slash_atvbaha__119__312754-103-9-16 Average 96 stars, based on 1 article reviews
magnetic activated cell sorted lineage cell depletion kit - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd34 cells ![]() Cd34 Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/CD34+MicroBead+Kit%2C+human/bio_rxiv__2023__04__07__535928-100-8-24 Average 97 stars, based on 1 article reviews
cd34 cells - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
multi tissue dissociation kits miltenyi ![]() Multi Tissue Dissociation Kits Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/Multi+Tissue+Dissociation+Kit+1/pm38897198-276-169-173 Average 96 stars, based on 1 article reviews
multi tissue dissociation kits miltenyi - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
neutrophil isolation kit ![]() Neutrophil Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/Neutrophil+Isolation+Kit%2C+mouse/pm32669546-317-34-39 Average 96 stars, based on 1 article reviews
neutrophil isolation kit - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
R&D Systems
human flt3l ![]() Human Flt3l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/magnetic+activated+cell+separation+system/Human+Flt-3+Ligand%2FFLT3L+XL+Luminex%C2%AE+Performance+Assay/pm17330086-152-61-67 Average 93 stars, based on 1 article reviews
human flt3l - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia
doi: 10.1101/2023.04.07.535928
Figure Lengend Snippet: A) UMAP of scDNA and protein-seq data for pooled MNCs isolated from BM samples obtained from a CMML patient with pre-existing KRAS T58K and NRAS G12R mutations at diagnosis (n=1,826) and at BP after HMA therapy failure (n=4,001). BP was not associated with the clonal evolution of these mutations as they both had a VAF of approximately 50% at the onset of the disease. Each dot represents one cell. Cells are clustered based on immunophenotypic markers. Different colors represent cluster identity (left) or origin (right). Mono, monocytes; Ery, erythroblasts; cDC, classical dendritic cells; CD4T, CD4 + T-cells; MyHPC, myeloid hematopoietic progenitor cells; CD8T, CD8 + T-cells; NKC, natural killer cells. (B) Heatmap displaying DNA and protein reads from each sequenced cell type shown in . Colors for protein data correspond to antibody-oligonucleotide intensity signals. High protein expression is depicted in red and low protein expression is depicted in blue. DNA colors correspond to the genotypes for each individual mutation per cell read (wild-type=dark grey, mutant=red, missing=light grey) based on cluster. Percentages correspond to the frequencies of mutant reads within each cluster for a given mutation. C) UMAP of scDNA and protein-seq data for pooled MNCs isolated from BM samples obtained from a CMML patient at diagnosis (n=3,213) and at BP after HMA therapy failure (n=5,342). BP was associated with the clonal evolution of a pre-existing CBL F378Ifs mutation and the acquisition of a previously undetected CBL C384Y mutation. Each dot represents one cell. Cells are clustered based on immunophenotypic markers. Different colors represent cluster identity (left) or origin (right). Mono, monocytes; Ery, erythroblasts; DC, classical dendritic cells; CD4T, CD4 + T-cells; B-cell, B lymphocytes, myeloid hematopoietic progenitor cells; CD8T, CD8 + T-cells; NKC, natural killer cells. (D) Heatmap displaying DNA and protein reads from each sequenced cell type as shown in . Colors for protein data correspond to antibody-oligonucleotide intensity signals. Red indicates high protein expression, and blue indicates low protein expression. Colors for DNA data correspond to the genotype for each individual mutation per cell read (dark grey, wild type; red, mutant; light grey, missing) based on cluster. Percentages correspond to the frequencies of mutant reads within each cluster for a given mutation.
Article Snippet: For cell sorting applications, MNCs were enriched in
Techniques: Isolation, Biomarker Discovery, Expressing, Mutagenesis
Journal: bioRxiv
Article Title: Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia
doi: 10.1101/2023.04.07.535928
Figure Lengend Snippet: (A) UMAP of scRNA-seq data for pooled single Lin − CD34 + cells isolated from BM samples of 2 HDs (n=895) and 5 CMML patients (n=3,161). Each dot represents one cell. Different colors represent the cluster cell type identity (left) or sample origin (right). HSC, hematopoietic stem cells; eMyHPC, early myeloid progenitor cells; dMyHPC, differentiated myeloid progenitors; Ery/MkHPC, erythroid/megakaryocyte hematopoietic progenitor cells. Dashed lines indicate single clusters in each cell type population. (B) Distribution of HD (top) and CMML (bottom) Lin − CD34 + cell types among the clusters shown in . (C) Pathway enrichment analysis of the genes that were significantly upregulated in HSCs (left), eMyHPCs (middle), and dMyHPCs (right) from CMML samples compared with those from HD samples (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown. (D) UMAP of scRNA-seq data for pooled single MNCs isolated from BM samples of 3 HDs (n=9,896) and 5 CMML patients (n=9,319). Each dot represents one cell. Different colors represent the cluster cell type identity (left) or sample origin (right). HSC, hematopoietic stem cells; MKP, megakaryocyte precursors; MyHPC, myeloid hematopoietic progenitor cells; Mono, monocytes; cDC, classical dendritic cells; pDC, plasmacytoid dendritic cells; Prog B, progenitor B-cells; PC, plasma cells; Pre-Ery, pre-erythrocytes; Ery-E, early erythroid precursors; Ery-L, late erythroid precursors; nCD4T, naïve CD4 + T cells; nmCD4T, naïve and memory CD4 + T cells; mCD4T, memory CD4 + T cells; nCD8T, naïve CD8 + T cells; nmCD8T, naïve and memory CD8 + T cells; eCD8T, effector CD8 + T cells; NKC, natural killer cells. Dashed lines indicate single clusters in each cell type population. (E) Distribution of HD (top) and CMML (bottom) cell types among the clusters shown in . (F) Pathway enrichment analysis of the genes that were significantly upregulated in the CMML monocyte clusters compared with those in the HD monocyte clusters shown in (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown.
Article Snippet: For cell sorting applications, MNCs were enriched in
Techniques: Isolation, Clinical Proteomics
Journal: bioRxiv
Article Title: Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia
doi: 10.1101/2023.04.07.535928
Figure Lengend Snippet: (A) UMAP of scRNA-seq data for pooled single Lin − CD34 + cells isolated from BM samples of 5 CMML patients at diagnosis (n=1,840) and at BP after HMA therapy failure (n=1,711). Each dot represents one cell. Different colors represent the cluster cell type identity (left) or sample origin (right). HSC, hematopoietic stem cells; eMyHPC, early myeloid hematopoietic progenitor cells; dMyHPC, differentiated myeloid hematopoietic progenitor cells; Ery/MkHPC, erythroid/megakaryocyte hematopoietic progenitor cells. Dashed lines indicate single clusters in each cell type population. (B) Distribution of Lin − CD34 + cell types at diagnosis (top) and BP (bottom) among the clusters shown in . (C) Pathway enrichment analysis of the genes that were significantly upregulated in HSCs (left) and dMyHPCs (right) at the time of BP after HMA therapy failure compared with those at diagnosis (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown. (D) UMAP of scATAC-seq data for pooled Lin − CD34 + cells isolated from BM samples obtained from a CMML patient at diagnosis (n=2,027) and at BP after HMA therapy failure (n=2,895). Each dot represents one cell. Different colors represent the cluster identity (left) or sample of origin (right). HSC, hematopoietic stem cells; MyHPC, myeloid progenitor cells; Ery/MkHPC, erythroid/megakaryocyte hematopoietic progenitor cells. (E) Pathway enrichment analysis of genes whose distal elements were enriched in open chromatin regions in HSCs (cluster 1, shown in ) at the time of BP as compared with those at diagnosis (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown.
Article Snippet: For cell sorting applications, MNCs were enriched in
Techniques: Isolation, Biomarker Discovery
Journal: bioRxiv
Article Title: Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia
doi: 10.1101/2023.04.07.535928
Figure Lengend Snippet: (A) UMAP of scRNA-seq data for pooled single MNCs isolated from BM samples of 6 CMML patients at diagnosis (n=16,372) and at BP after HMA therapy failure (n=19,541). Each dot represents one cell. Different colors represent the cluster cell type identity (left) or sample of origin (right). MyHPC, myeloid hematopoietic progenitors; My/MoP, myelo/monocytic progenitors; Mono, monocytes; cDC, classical dendritic cells; pDC, plasmacytoid dendritic cells; MKP, megakaryocyte precursors; Ery-E, early erythroid precursors; Ery-L, late erythroid precursors; B-cell, B lymphocytes; PC, plasma cells; nCD4T, naïve CD4 + T cells; mCD4T, memory CD4 + T-cells; eCD8T, effector CD8 T-cells, NKC, natural killer cells. Dashed lines indicate single clusters in each cell type population. (B) Distribution of MNC types at diagnosis (top) and (bottom) among the clusters shown in . (C) Pathway enrichment analysis of the genes that were significantly upregulated in the monocytic populations shown in the time of BP after HMA therapy failure compared with those at the time of diagnosis (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown. (D) Numbers of live Lin − CD34 + CD38 − HSCs and Lin − CD34 + CD38 + MyHPCs from CMML patients with BP after treatment with vehicle or 20 nM AMG-176 (n=4) for 48 h. Lines represent means ± SDs. Statistical significance was calculated using a two-tailed Student’s t- test (*** P <0.001; **** P <0.0001). (E) UMAP of scRNA-seq data for pooled single MNCs isolated from BM samples obtained from a representative CMML patient at the time of BP after HMA therapy failure (n=6,209) and after the failure of venetoclax-based therapy (n=6,795). Each dot represents one cell. Different colors represent the cluster cell type identity (left) or the sample of origin (right). HSC, hematopoietic stem cells; MyHPC, myeloid hematopoietic progenitor cells; My/MoP, myelo/monocytic progenitors; Mono, monocytes; Ery/MkHPC, erythroid/megakaryocytic hematopoietic progenitor cells; Ery-E, early erythroid precursors; Ery-L, late erythroid precursors; Pre-E, pre-erythrocytes; mCD8T, memory CD8 + T cells; eCD8T, effector CD8 + T cells; NKC, natural killer cells. (F) Pathway enrichment analysis of the genes that were significantly upregulated in MyHPCs at the time of venetoclax failure compared with those at the time of HMA therapy failure (adjusted P ≤ 0.05). The top 10 Hallmark gene sets are shown. (G) Distribution of myeloid cell types among the myeloid compartments at HMA therapy (top) and venetoclax-based therapy (bottom) failure. (H) Proposed working model of RAS pathway–mutated CMML initiation and progression after HMA and venetoclax-based therapies. Compared with physiological adult hematopoiesis (top left), RAS pathway–mutated CMML HSPCs undergo proliferation and monocytic differentiation in response to inflammatory responses while maintaining an intact apoptotic program. Inflammatory reprograming is exacerbated in downstream monocytic populations, which contributes to disease maintenance (bottom left). At BP after HMA therapy failure, RAS pathway–mutated CMML HSCs undergo epigenetic reprogramming and drive the expansion of downstream MyHPCs. MyHPCs and downstream monocytes rely on NF- K B signaling–mediated anti-apoptotic pathways to maintain survival and suppress the immune microenvironment (bottom right). NF- K B signaling–mediated survival pathway activation persists after venetoclax therapy and leads to treatment resistance and failure (top right).
Article Snippet: For cell sorting applications, MNCs were enriched in
Techniques: Isolation, Biomarker Discovery, Clinical Proteomics, Two Tailed Test, Activation Assay
Journal: Nature communications
Article Title: Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling.
doi: 10.1038/s41467-020-17402-2
Figure Lengend Snippet: Fig. 1 LPS increases glycolysis as well as lactate production by BM neutrophils. a Flow cytometry quantitative analysis of 2-NBDG-glucose uptake by BM neutrophils (CD11bhighLy6Ghigh cells; n = 6) 4 h following i.p. administration of LPS in vivo in wild-type (WT) mice. b Gene expression of glycolytic enzymes in sorted BM neutrophils from WT mice following LPS treatment (n = 3, PBS; n = 5, LPS). On each box, the bottom, middle, and the top edges indicate the 25th, 50th, and 75th percentiles, respectively. The whiskers extend to the most extreme data points. c Quantitative analysis and representative histogram plot showing mean fluorescent intensity (MFI) of ROS production in BM neutrophils following LPS administration (n = 9). d Percentage of HIF-1α+ neutrophils in the BM following LPS administration (n = 11). e Quantitative analysis and representative histogram plot of LDHA expression in BM neutrophils following LPS treatment (n = 7). ***p(0.0003). f BM lactate levels in WT mice treated with PBS, LPS, or LPS followed by α-Ly6G Ab (n = 7). g Lactate levels released from isolated BM neutrophils treated ex vivo with PBS or LPS (120 ng/ml; n = 4 mice).**p(0.0063). h MCT4, MCT1, and GPR81 (yellow) distribution on BM CD11b+ (green)/Ly6G+ (red) neutrophils visualized and quantified by ImageStream analysis. Images are from one representative experiment out of three. Scale bar indicates 7 μm. i Quantitative analysis of MCT4 expression on BM neutrophils 4 h following LPS administration (n = 7). j A scheme of the proposed mode of action of LPS in lactate production by BM neutrophils. Data are represented as mean ± SEM from 3 to 4 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, Student’s two-tailed unpaired t test (a, c–e, g, i), one-way ANOVA with Tukey’s post hoc test (f, h) or two-way ANOVA with Tukey’s post hoc test (b). See also Supplementary Fig. 1.
Article Snippet: Flushed BM cells (from WT and mutated mice) were resuspended in 200 μl MACS buffer (2 mM EDTA, 0.5% bovine serum albumin in PBS) and BM neutrophils were isolated according to the protocol of
Techniques: Flow Cytometry, In Vivo, Gene Expression, Expressing, Isolation, Ex Vivo, Two Tailed Test
Journal: Nature communications
Article Title: Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling.
doi: 10.1038/s41467-020-17402-2
Figure Lengend Snippet: Fig. 3 Lactate production by neutrophils requires NOX/ROS signaling. a Percentage of BM HIF-1α+ neutrophils in WT (n = 9) and gp91phox−/−(n = 7) mice treated with either PBS or LPS. **p(WT + LPS vs. gp91phox−/−+LPS) = 0.0012. b Quantitative analysis and representative histogram plot showing LDHA expression in BM neutrophils from WT (n = 5) and gp91phox−/−(n = 4) mice. **p(WT + PBS vs. WT + LPS) = 0.0054; *p(WT + LPS vs. gp91phox−/−
Article Snippet: Flushed BM cells (from WT and mutated mice) were resuspended in 200 μl MACS buffer (2 mM EDTA, 0.5% bovine serum albumin in PBS) and BM neutrophils were isolated according to the protocol of
Techniques: Expressing
Journal: Nature communications
Article Title: Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling.
doi: 10.1038/s41467-020-17402-2
Figure Lengend Snippet: Fig. 7 Salmonella increases lactate production by inflammatory BM neutrophils. a, b Lactate levels in (a) BM or (b) blood from WT mice treated with PBS or Salmonella (n = 5). a ***p(0.0004); b **p(0.0081). c Quantitative analysis of ROS production in BM neutrophils from WT (n = 7) vs. gp91phox−/−
Article Snippet: Flushed BM cells (from WT and mutated mice) were resuspended in 200 μl MACS buffer (2 mM EDTA, 0.5% bovine serum albumin in PBS) and BM neutrophils were isolated according to the protocol of
Techniques:
Journal: Nature communications
Article Title: Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling.
doi: 10.1038/s41467-020-17402-2
Figure Lengend Snippet: Fig. 8 Mechanisms of lactate-induced neutrophil mobilization from the BM. Our model suggests that enhanced lactate-produced by BM neutrophils during bacterial infection induces neutrophil mobilization by modulating metabolic signaling in BM endothelial cells. LPS binds TLR4 expressed on neutrophils that directly activates NADPH oxidase (NOX) and enhances glucose uptake via a glucose transporter 1a. Glucose in turn, is converted to pyruvate by the glycolysis pathway 1b. NOX activity leads to ROS production (2) which elevates HIF-1α expression. HIF-1α in turn, induces downstream expression of LDHA that converts pyruvate to lactate 3a. HIF-1α also up-regulates the lactate transporter MCT4 3b to allow lactate release (4). Under steady-state conditions, surface VE–cadherin on endothelial cells (ECs) is highly expressed, which maintains the endothelial barrier integrity with low permeability (a). During inflammation (b), lactate released from BM neutrophils binds to GPR81 on sinusoidal BM endothelial cells 5a, activates Gi protein and thereby reduces cAMP/Epac1 activity 5b. Consequently, lactate via GPR81 signaling decreases surface VE–cadherin expression (5c), leading to higher BM vascular permeability (6). In addition, lactate elevates CXCL1 and G-CSF levels (produced by different cells including ECs50,52) also in a GPR81- independent manner 7a with more moderate increases in CXCL2 levels in WT mice (most probably produced by BM neutrophils50). Lactate-induced elevation of CXCL1, CXCL2, and G-CSF downregulates surface CXCR2 expression on PB neutrophils 7b facilitating neutrophil mobilization (8). Taken together, LPS-induced lactate promotes rapid neutrophil mobilization from the BM to the blood (8) preferentially via BM GPR81/VE–cadherin-dependent (5–6) and also by GPR81-independent (7) pathways.
Article Snippet: Flushed BM cells (from WT and mutated mice) were resuspended in 200 μl MACS buffer (2 mM EDTA, 0.5% bovine serum albumin in PBS) and BM neutrophils were isolated according to the protocol of
Techniques: Produced, Infection, Activity Assay, Expressing, Permeability
Journal: Gene therapy
Article Title: Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
doi: 10.1038/sj.gt.3302930
Figure Lengend Snippet: Figure 2 Transduction of porcine BMHC, HSC, Flt3L-DC, mono- cytes and MoDC by LV. Freshly isolated BMHC (a, b), enriched HSC (c, d), Flt3L-DC (e, f), freshly isolated monocytes (g, h), or MoDC (i, j) were transduced with different doses (0.1, 1 and 10 TU cell1 – x axis) of LV-THM, and eGFP expression analysed by flow cytometry after 4 days. The average from three independent experiments with s.d. error bars are shown. In (b, d, f, h, j), the histograms show representative profiles from a single experiment after transduction with an MOI 10 TU cell1.
Article Snippet: HSCs were enriched by MACS sorting for c-Kit expressing BMHC as described previously.58 Generation of BMHC-derived DC using Flt3 ligandinduced DC (Flt3L-DC) For the generation of Flt3L-DC, BMHCs were plated in 6-well plates at a rate of 5 105 cells ml 1 in Iscove’s modified Dulbecco’s medium (Invitrogen) containing 10% fetal bovine serum (Sigma Chemicals), supplemented with antibiotics (penicillin/streptomycin, Invitrogen) and
Techniques: Transduction, Isolation, Expressing, Cytometry
Journal: Gene therapy
Article Title: Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
doi: 10.1038/sj.gt.3302930
Figure Lengend Snippet: Figure 3 Influence of LV on DC maturation and activation. MoDC (a) or Flt3L-DC (b) was transduced by LV-THM at a MOI of 10 TU cell1, and the levels of MHC class II and CD80/86 were analysed by flow cytometry after 2 days. The data shown are representative from three independent experiments. The grey histogram shows the medium control (no stimulant), the black line shows the cells transduced with the LV-THM, and the grey line shows a positive control of stimulated cells in which IFN-a/TNF had been applied. In (c), freshly isolated, enriched pDCs (CD172a+CD4+ PBMC) were transduced with different doses (0.1 and 1 TU cell1) of LV-THM. After 16 h of culture, INF-a secretion was quantified. In (d), PBMCs were separated into CD4+, CD4, CD14+ and CD14 fractions before transducing with 1 TU cell1 of LV-THM. IFN-a secretion was measured in the supernatants after 16 h. These data are from two independent experiments.
Article Snippet: HSCs were enriched by MACS sorting for c-Kit expressing BMHC as described previously.58 Generation of BMHC-derived DC using Flt3 ligandinduced DC (Flt3L-DC) For the generation of Flt3L-DC, BMHCs were plated in 6-well plates at a rate of 5 105 cells ml 1 in Iscove’s modified Dulbecco’s medium (Invitrogen) containing 10% fetal bovine serum (Sigma Chemicals), supplemented with antibiotics (penicillin/streptomycin, Invitrogen) and
Techniques: Activation Assay, Cytometry, Control, Transduction, Positive Control, Isolation
Journal: Gene therapy
Article Title: Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
doi: 10.1038/sj.gt.3302930
Figure Lengend Snippet: Figure 4 Functional response of porcine cDC to TLR ligands. MoDC (a) or Flt3L-DC (b) was stimulated with CpG ODN; LPS or R837, and the levels of MHC class II and CD80/86 analysed by flow cytometry after 2 days. (c) IL-6 secretion in supernatants TLR ligand stimulated MoDC and Flt3L-DC at 16 h post-stimulation. (d) TLR7 and TLR9 mRNA levels, measured by real-time PCR in Flt3L-DC compared with MoDC.
Article Snippet: HSCs were enriched by MACS sorting for c-Kit expressing BMHC as described previously.58 Generation of BMHC-derived DC using Flt3 ligandinduced DC (Flt3L-DC) For the generation of Flt3L-DC, BMHCs were plated in 6-well plates at a rate of 5 105 cells ml 1 in Iscove’s modified Dulbecco’s medium (Invitrogen) containing 10% fetal bovine serum (Sigma Chemicals), supplemented with antibiotics (penicillin/streptomycin, Invitrogen) and
Techniques: Functional Assay, Cytometry, Real-time Polymerase Chain Reaction